Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 8.4B | 8.7B | 8.3B |
Cost of revenue | 5.4B | 5.2B | 5.5B | 5.1B |
Gross profit | 3.4B | 3.2B | 3.1B | 3.2B |
Operating expense | ||||
Research & development | 412.5M | 376.4M | 365.3M | 315.6M |
Selling general and admin | 1.2B | 1.2B | 1.2B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.7B | 1.6B | 1.7B |
Non operating interest income | ||||
Income | 67.7M | 77.2M | 86.6M | 94.3M |
Expense | 283.0M | 245.2M | 249.5M | 254.7M |
Other income expense | 6.9M | 81.5M | -90.0M | 24.0M |
Pretax income | 1.6B | 1.6B | 1.3B | 1.6B |
Tax provision | 259.0M | 357.6M | 217.8M | 350.7M |
Net income | 1.3B | 1.3B | 1.1B | 1.2B |
Basic EPS | 2.5 | 2.2 | 2.0 | 2.2 |
Diluted EPS | 2.5 | 2.2 | 2.0 | 2.2 |
Basic average shares | 546.7M | 555.8M | 557.9M | 557.7M |
Diluted average shares | 549.6M | 558.8M | 561.5M | 560.9M |
EBITDA | 2.3B | 2.2B | 2.0B | 2.2B |
Net income from continuing op. | 1.3B | 1.3B | 1.1B | 1.2B |
Minority interests | 857.5K | -15.4M | -4.3M | -1.7M |
Preferred stock dividends | — | — | — | — |